Hypertension: all 6,834 studies

Page 17 of 69. Open to participants first (972), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Dietary Sodium Restriction of Improving Vascular Endothelial Function in Middle Aged and Older AdultsCompletedNCT01566084Not applicableResults posted
• A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Patients Treated With EprosartanCompletedNCT01562613Results posted
• An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial HypertensionCompletedNCT01560637Phase 3Results posted
• Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral MonotherapyCompletedNCT01560624Phase 3Results posted
• Assessmet of Patients With PAH Right Ventricular VolumeCompletedNCT01557582Not applicableResults posted
• Perindopril Amlodipine for the Treatment of HypertensionCompletedNCT01556997Phase 3Results posted
• Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With OlmesartanCompletedNCT01552954Phase 4Results posted
• Anastrozole in Patients With Pulmonary Arterial HypertensionCompletedNCT01545336Phase 2Results posted
• Treatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty CatheterCompletedNCT01541865Not applicableResults posted
• Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)CompletedNCT01540370Results posted
• The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy VolunteersCompletedNCT01530464Phase 1Results posted
• Pilot Study About the Harmful Effects of Blood Storage on Overweight People and the Role of iNO in This SettingCompletedNCT01529502Phase 2Results posted
• Study of AR-13324 in Patients With Elevated Intraocular PressureCompletedNCT01528787Phase 2Results posted
• A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular HypertensionCompletedNCT01525173Phase 4Results posted
• A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial FunctionCompletedNCT01522950Phase 2Results posted
• Rapid Renal Sympathetic Denervation for Resistant HypertensionCompletedNCT01520506Not applicableResults posted
• Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With HypertensionCompletedNCT01519635Phase 4Results posted
• Nesiritide in Resistant HypertensionTerminatedNCT01514357Phase 1/2Results posted
• Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedNCT01510145Phase 4Results posted
• Comparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive PatientsCompletedNCT01508325Phase 4Results posted
• Renal Denervation for Management of Drug-Resistant HypertensionCompletedNCT01505010Not applicableResults posted
• Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive PatientsCompletedNCT01502787Phase 4Results posted
• Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive PatientsCompletedNCT01501929Phase 4Results posted
• Efficacy and Safety of Radiofrequency Renal Denervation in Drug Resistant HypertensionCompletedNCT01499810Not applicableResults posted
• Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up StudyCompletedNCT01499511Results posted
• Effect of Febuxostat on Blood PressureCompletedNCT01496469Phase 2Results posted
• Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesTerminatedNCT01496430Phase 3Results posted
• Safety Study of Lisinopril in Children and Adolescents With a Kidney TransplantCompletedNCT01491919Phase 1Results posted
• Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT01489670Results posted
• A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial HypertensionCompletedNCT01484431Phase 1/2Results posted
• Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary HypertensionTerminatedNCT01479010Phase 1/2Results posted
• Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®CompletedNCT01477333Phase 2Results posted
• Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood PressureCompletedNCT01472692Phase 4Results posted
• Epoprostenol for Injection in Patients With Pulmonary Arterial HypertensionCompletedNCT01470144Phase 3Results posted
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)CompletedNCT01464424Phase 4Results posted
• Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)CompletedNCT01462565Phase 4Results posted
• Shiga Microalbuminuria Reduction Trial-2CompletedNCT01461499Phase 4Results posted
• Home Versus Ambulatory Monitoring, Diurnal Blood Pressure Profile, Detection of Non-DippersCompletedNCT01460732Not applicableResults posted
• A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil AloneCompletedNCT01456169Phase 3Results posted
• Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in GermanyCompletedNCT01454583Results posted
• Travoprost 3-Month Safety and Efficacy StudyCompletedNCT01453855Phase 3Results posted
• IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) PatientsCompletedNCT01447628Phase 2Results posted
• A Study of the Effect of MK-8457 on Blood Pressure in Hypertensive Participants (MK-8457-004-AM1)CompletedNCT01446003Phase 1Results posted
• Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)CompletedNCT01445873Results posted
• High MAP in Septic Shock With HypertensionCompletedNCT01443494Not applicableResults posted
• The Impact of Nebivolol Versus Metoprolol on Quality of LifeTerminatedNCT01441570Not applicableResults posted
• Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension PatientsCompletedNCT01438229Not applicableResults posted
• Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT01437878Phase 2Results posted
• Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial HypertensionCompletedNCT01431716Phase 3Results posted
• A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)CompletedNCT01431508Phase 4Results posted
• Inhaled Nitrite in Subjects With Pulmonary HypertensionCompletedNCT01431313Phase 2Results posted
• A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%CompletedNCT01426867Phase 2Results posted
• 52-104 Week Off-therapy Second Extension to Study CSPP100A2365CompletedNCT01420068Results posted
• Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)CompletedNCT01416636Phase 3Results posted
• Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)CompletedNCT01415531Phase 4Results posted
• Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in CanadaCompletedNCT01415401Phase 4Results posted
• Pharmacogenetics of Ace Inhibitor-Associated AngioedemaCompletedNCT01413542Not applicableResults posted
• Study of Sildenafil to Treat Newborns With Persistent Pulmonary HypertensionTerminatedNCT01409031Phase 2Results posted
• The Chronic Effects of Beetroot Juice in Hypertensive SubjectsCompletedNCT01405898Not applicableResults posted
• Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)TerminatedNCT01392495Phase 3Results posted
• Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension ParticipantsCompletedNCT01392469Phase 3Results posted
• A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)CompletedNCT01390415Results posted
• Titrated Disease Management for Patients With HypertensionCompletedNCT01390272Not applicableResults posted
• Persistent Pulmonary Hypertension of the NewbornTerminatedNCT01389856Phase 3Results posted
• Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)CompletedNCT01371747Phase 2Results posted
• A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)CompletedNCT01370655Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and DiabetesTerminatedNCT01368536Phase 4Results posted
• Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)CompletedNCT01368185Results posted
• Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial HypertensionCompletedNCT01365585Results posted
• Safety and Tolerability of Valsartan in Children 6 to 17 Years of AgeCompletedNCT01365481Phase 3Results posted
• Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01357616Phase 3Results posted
• Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy VolunteersCompletedNCT01353508Phase 2Results posted
• Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With HypertensionCompletedNCT01353274Results posted
• Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With ObesityTerminatedNCT01351753Phase 2Results posted
• Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic SubjectsTerminatedNCT01349114Phase 4Results posted
• DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01343082Phase 3Results posted
• Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529CompletedNCT01342952Phase 2Results posted
• DE-111 Against Timolol Ophthalmic Solution 0.5%CompletedNCT01342094Phase 3Results posted
• DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%CompletedNCT01342081Phase 3Results posted
• Patient Preference Comparison of AZARGA Versus COSOPTCompletedNCT01340014Phase 4Results posted
• An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH)CompletedNCT01338636Phase 4Results posted
• FUTURE 3 Study ExtensionCompletedNCT01338415Phase 3Results posted
• Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)CompletedNCT01337674Phase 1Results posted
• Efficacy and Safety of Ambrisentan in Children 8-18yrsTerminatedNCT01332331Phase 2Results posted
• Safely Change From Bosentan to Ambrisentan in Pulmonary HypertensionCompletedNCT01330108Phase 4Results posted
• Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)CompletedNCT01328769Phase 4Results posted
• Efficacy of Changing to DUOTRAV® From Prior TherapyCompletedNCT01327599Phase 4Results posted
• Tadalafil for Sarcoidosis Associated Pulmonary HypertensionCompletedNCT01324999Phase 2/3Results posted
• Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart DiseaseTerminatedNCT01319045Not applicableResults posted
• Twynsta Study With Lifestyle Modifications in Korean Patients With HypertensionCompletedNCT01316419Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01310777Phase 3Results posted
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01309204Phase 3Results posted
• MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)CompletedNCT01307046Phase 3Results posted
• A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)CompletedNCT01307033Phase 3Results posted
• Safety of SonoVue on Pulmonary HemodynamicsCompletedNCT01306292Phase 2Results posted
• A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).CompletedNCT01305252Phase 4Results posted
• MK-0954E Study in Participants With Hypertension (MK-0954E-357)CompletedNCT01302691Phase 3Results posted
• Treprostinil Combined With Tadalafil for Pulmonary HypertensionTerminatedNCT01302444Phase 4Results posted
• MK-0954E Phase III Long-Term Study in Participants With Hypertension (MK-0954E-356)CompletedNCT01299376Phase 3Results posted
• Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedNCT01298700Phase 4Results posted

← Hypertension overview